C4 Therapeutics Inc. (NASDAQ: CCCC)
$3.9500
+0.2100 ( +2.87% ) 700.7K
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
Market Data
Open
$3.9500
Previous close
$3.7400
Volume
700.7K
Market cap
$278.12M
Day range
$3.6960 - $4.0700
52 week range
$3.3800 - $11.8800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
sc | Insider transactions | 1 | Nov 14, 2024 |
sc | Insider transactions | 1 | Nov 14, 2024 |
sc | Insider transactions | 1 | Nov 14, 2024 |
sc | Insider transactions | 1 | Nov 14, 2024 |
sc | Insider transactions | 1 | Nov 14, 2024 |
sc | Insider transactions | 1 | Nov 14, 2024 |
effect | Other | 1 | Nov 13, 2024 |
effect | Other | 1 | Nov 13, 2024 |
suppl | Other | 4 | Nov 13, 2024 |
suppl | Other | 2 | Nov 13, 2024 |